Views & Analysis Getting patients round the virtual table If pharma wants to be truly patient-centric, it needs to be talking to patients.
Views & Analysis Why pharma needs to care about global warming Barely a day goes by without global warming or climate change (now more appropriately termed “climate crisis” by some media outlets) being in the news.
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
